Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

CIRM provides funding across all stages of research, from basic science to translational studies and clinical trials. This support drives best-in-class research aimed at developing innovative ...

Many stem cell clinics, both in the United States and in other countries, advertise cures for a price. Understand the concerns over stem cell tourism and what CIRM is doing to bring real cures to ...

The Alpha Clinics Network is funded and supported by the California Institute for Regenerative Medicine (CIRM). The Network features nine world-class medical centers throughout California with a ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

When most people think about about stem cells treating disease they think of a stem cell transplant. In a stem cell transplant, stem cells are first specialized into the necessary adult cell type.

The following information will help you comply with CIRM regulations and find information about our forms and policies. If you have questions that aren’t addressed on this page contact your Grants ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

CIRM’s Education and Training programs are a vital link to tomorrow. The California Institute for Regenerative Medicine (CIRM) offers invaluable educational and training pathways in regenerative ...

目前存在多种培养技术可在体外长期维持新生原代小鼠肠道类器官； 然而，迄今为止，在培养的类器官中实现收缩行为的情况很少见且不可预测。 在这里，我们结合氧运输的有限元模拟和细胞微环境的定量比较分析，以阐明促进可重复的肠道类器官收缩的关键 ...

CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

Researchers at the California Institute for Biomedical Research (CALIBR) have been awarded $8.447 million to test KA34, a drug that, in preclinical tests, recruits stem cells to create new cartilage ...